Gurnet Point Capital
Gurnet Point Capital is a San Francisco-based investment firm that focuses on the life sciences industry. They invest in companies that have scientifically de-risked products, aiming to bring safe and effective treatments to market while generating significant returns for investors.
With an active ownership approach, Gurnet Point Capital takes control positions in their portfolio companies, leveraging the expertise of their investment and operations team to navigate key value inflection points. Their investments typically target companies that have reached post Phase 3 data, ensuring the availability of toxicology data and proven treatment safety.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.


